A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
- Status
- COMPLETED
- Phase
- PHASE2
iCAT for Recurrent/Refractory/HR Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks
- Status
- COMPLETED
- Phase
- NA
Project A: Integrated Approaches to Improving the Health and Safety of Health Care Workers
- Status
- COMPLETED
- Phase
- NA
Mumbai Worksite Tobacco Control Study
- Status
- COMPLETED
- Phase
- NA
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
- Status
- COMPLETED
- Phase
- NA
Tivozanib + Gemcitabine in Metastatic RCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Sunitinib in Never-Smokers With Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Eribulin in HER2 Negative Metastatic BrCa
- Status
- COMPLETED
- Phase
- PHASE2
NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Melatonin Versus Placebo in Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- NA
Clofarabine for Langerhans in Pedi
- Status
- WITHDRAWN
- Phase
- PHASE2
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
- Status
- COMPLETED
- Phase
- PHASE2
BKM120 For Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Regadenoson in Sickle Cell Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Serious Illness Communication Project
- Status
- COMPLETED
- Phase
- NA